Literature DB >> 31150733

Clinical-pathological correlations of BAV and the attendant thoracic aortopathies. Part 1: Pluridisciplinary perspective on their hemodynamics and morphomechanics.

Ares Pasipoularides1.   

Abstract

Clinical BAV manifestations pertain to faulty aortic valve (AOV) function, the associated aortopathy, and other complications such as endocarditis, thrombosis and thromboembolism. BAV arises during valvulogenesis when 2 of the 3 leaflets/cusps of the AOV are fused together. Ensuing asymmetric BAV morphologies alter downstream ejection jet flow-trajectories. Based on BAV morphologies, ejection-flows exhibit different wall-impingement and scouring patterns in the proximal aorta, with excessive hydrodynamic wall-shear that correlates closely with mural vascular smooth muscle cell and extracellular matrix disruptions, revealing hemodynamic participation in the pathogenesis of BAV-associated aortopathies. Since the embryologic regions implicated in both BAV and aortopathies derive from neural crest cells and second heart field cells, there may exist a common multifactorial/polygenic embryological basis linking the abnormalities. The use of Electronic Health Records - encompassing integrated NGS variant panels and phenotypic data - in clinical studies could speed-up comprehensive understanding of multifactorial genetic-phenotypic and environmental factor interactions. This Survey represents the first in a 2-article pluridisciplinary work. Taken in toto, the series covers hemodynamic/morphomechanical and environmental (milieu intérieur) aspects in Part 1, and molecular, genetic and associated epigenetic aspects in Part 2. Together, Parts 1-2 should serve as a reference-milestone and driver for further pluridisciplinary research and its urgent translations in the clinical setting.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  BAV-aortopathy; BAV-associated syndromes or disease; Bicuspid aortic valve (BAV); Calcific aortic valve disease; Cardiovascular magnetic resonance; Electronic health records; Extracellular matrix; Fluid–structure interaction; Hemodynamics; Personalized or precision medicine; Thoracic aortic aneurysm; Vascular smooth muscle cell; Wall shear stress

Mesh:

Year:  2019        PMID: 31150733      PMCID: PMC6629512          DOI: 10.1016/j.yjmcc.2019.05.017

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  123 in total

Review 1.  Fibrillin: from microfibril assembly to biomechanical function.

Authors:  Cay M Kielty; Clair Baldock; David Lee; Matthew J Rock; Jane L Ashworth; C Adrian Shuttleworth
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-02-28       Impact factor: 6.237

2.  Case-controlled study to assess risk factors for aortic stenosis in congenitally bicuspid aortic valve.

Authors:  K L Chan; M Ghani; K Woodend; I G Burwash
Journal:  Am J Cardiol       Date:  2001-09-15       Impact factor: 2.778

3.  RV functional imaging: 3-D echo-derived dynamic geometry and flow field simulations.

Authors:  Ares D Pasipoularides; Ming Shu; Michael S Womack; Ashish Shah; Olaf Von Ramm; Donald D Glower
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-09-12       Impact factor: 4.733

4.  The congenitally bicuspid aortic valve: how does it function? Why does it fail?

Authors:  Francis Robicsek; Mano J Thubrikar; Joseph W Cook; Brett Fowler
Journal:  Ann Thorac Surg       Date:  2004-01       Impact factor: 4.330

5.  Changes in size of ascending aorta and aortic valve function with time in patients with congenitally bicuspid aortic valves.

Authors:  Maros Ferencik; Linda A Pape
Journal:  Am J Cardiol       Date:  2003-07-01       Impact factor: 2.778

6.  Anomalous coronary artery origin and bicuspid aortic valve.

Authors:  S J Schang; C J Pepine; C R Bemiller
Journal:  Vasc Surg       Date:  1975 Mar-Apr

7.  Right ventricular diastolic function in canine models of pressure overload, volume overload, and ischemia.

Authors:  Ares Pasipoularides; Ming Shu; Ashish Shah; Scott Silvestry; Donald D Glower
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-11       Impact factor: 4.733

8.  Failure to prevent progressive dilation of ascending aorta by aortic valve replacement in patients with bicuspid aortic valve: comparison with tricuspid aortic valve.

Authors:  Hisayo Yasuda; Satoshi Nakatani; Marie Stugaard; Yuko Tsujita-Kuroda; Ko Bando; Junjiro Kobayashi; Masakazu Yamagishi; Masafumi Kitakaze; Soichiro Kitamura; Kunio Miyatake
Journal:  Circulation       Date:  2003-09-09       Impact factor: 29.690

9.  Vascular matrix remodeling in patients with bicuspid aortic valve malformations: implications for aortic dilatation.

Authors:  Paul W M Fedak; Mauro P L de Sa; Subodh Verma; Nafiseh Nili; Pedram Kazemian; Jagdish Butany; Bradley H Strauss; Richard D Weisel; Tirone E David
Journal:  J Thorac Cardiovasc Surg       Date:  2003-09       Impact factor: 5.209

10.  Time-resolved 3-dimensional velocity mapping in the thoracic aorta: visualization of 3-directional blood flow patterns in healthy volunteers and patients.

Authors:  Michael Markl; Mary T Draney; Michael D Hope; Jonathan M Levin; Frandics P Chan; Marcus T Alley; Norbert J Pelc; Robert J Herfkens
Journal:  J Comput Assist Tomogr       Date:  2004 Jul-Aug       Impact factor: 1.826

View more
  2 in total

1.  Plasma proteomic profiling reveals biomarkers associated with aortic dilation in patients with bicuspid aortic valve.

Authors:  Wenrui Ma; Jingjing Zhang; Kehua Xu; Shiqiang Yan; Dingqian Liu; Hui Huang; Yuyi Tang; Guoquan Yan; Yongxin Sun; Jun Li; Weijia Zhang; Chunsheng Wang; Kai Zhu; Hao Lai
Journal:  Ann Transl Med       Date:  2021-07

2.  A SOX17-PDGFB signaling axis regulates aortic root development.

Authors:  Pengfei Lu; Ping Wang; Bingruo Wu; Yidong Wang; Yang Liu; Wei Cheng; Xuhui Feng; Xinchun Yuan; Miriam M Atteya; Haleigh Ferro; Yukiko Sugi; Grant Rydquist; Mahdi Esmaily; Jonathan T Butcher; Ching-Pin Chang; Jack Lenz; Deyou Zheng; Bin Zhou
Journal:  Nat Commun       Date:  2022-07-13       Impact factor: 17.694

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.